Pathak, Prathamesh <br/><br/>
Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.  [electronic resource] 

 -  Psychiatric services (Washington, D.C.)  Feb 2010 
 - 123-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-9700 
<br/><br/><label>Standard No.: </label>10.1176/ps.2010.61.2.123  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antipsychotic Agents--adverse effects<br/>Aripiprazole<br/>Benzodiazepines--adverse effects<br/>Child<br/>Child, Preschool<br/>Clozapine--adverse effects<br/>Dibenzothiazepines--adverse effects<br/>Drug Utilization--statistics & numerical data<br/>Evidence-Based Medicine<br/>Female<br/>Humans<br/>Infant<br/>Insurance Claim Review<br/>Male<br/>Medicaid<br/>Mental Disorders--drug therapy<br/>Off-Label Use<br/>Olanzapine<br/>Piperazines--adverse effects<br/>Quetiapine Fumarate<br/>Quinolones--adverse effects<br/>Risperidone--adverse effects<br/>Thiazoles--adverse effects<br/>United States<br/>United States Food and Drug Administration